Clinical Trials
3 trialsNCT00084422 2023-04-10
N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Completed
NCT00668421 2014-11-26
CEP-701 (Lestaurtinib) in Myelofibrosis
Icahn School of Medicine at Mount Sinai
Phase 1/2 Unknown
NCT00494585 2012-06-25
CEP-701 for PH-negative Myelofibrosis
M.D. Anderson Cancer Center
Phase 2 Completed